Detalhe da pesquisa
1.
A drug discovery platform to identify compounds that inhibit EGFR triple mutants.
Nat Chem Biol;
16(5): 577-586, 2020 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32094923
2.
Drugging the undruggable proteins in cancer: A systems biology approach.
Curr Opin Chem Biol;
66: 102079, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34426091
3.
D154Q Mutation does not Alter KRAS Dimerization.
J Mol Biol;
434(2): 167392, 2022 01 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34896362
4.
B cell linker protein (BLNK) is a regulator of Met receptor signaling and trafficking in non-small cell lung cancer.
iScience;
25(11): 105419, 2022 Nov 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36388990
5.
Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches.
Oncogene;
40(24): 4079-4093, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34079087
6.
Mapping the Phospho-dependent ALK Interactome to Identify Novel Components in ALK Signaling.
J Mol Biol;
433(23): 167283, 2021 11 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34606829
7.
Chemical Genetics Screen Identifies COPB2 Tool Compounds That Alters ER Stress Response and Induces RTK Dysregulation in Lung Cancer Cells.
J Mol Biol;
433(23): 167294, 2021 11 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34662547